Axsome faces delay for depression drug, hitting shares hardThe FDA was supposed to be delivering its verdict on Axsome Therapeutics’ depression therapy AXS-05 in less than Share XAxsome faces delay for depression drug, hitting shares hardhttps://pharmaphorum.com/news/axsome-faces-delay-for-depression-drug-hitting-shares-hard/
